|
Anxiety Disorders
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.
|
31123309 |
2019 |
|
Adverse effects, not elsewhere classified
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.050 |
Biomarker
|
disease |
BEFREE |
ICA 12 antibodies were increased in either DR3 or DR4 (84% vs. 69%) positives compared to non-DR3/DR4 IDDM patients (P > 0.05).
|
12021135 |
2002 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.050 |
Biomarker
|
disease |
BEFREE |
We ascertained frequencies of autoantibodies to a suite of islet cell antigens including ICA512/IA2 and SOX13 in Asian Indians with Type 1 diabetes and in other forms of diabetes.
|
11323090 |
2001 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.050 |
Biomarker
|
disease |
BEFREE |
Linkage and association studies indicate that SOX13 is unlikely to make a substantial contribution to type 1 diabetes susceptibility.
|
11286511 |
2001 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.050 |
Biomarker
|
disease |
BEFREE |
SOX13 autoantibodies occurred at a significantly higher frequency among 188 people with type 1 diabetes (18%) than among 88 with type 2 diabetes (6%) or 175 healthy control subjects (4%).
|
10871192 |
2000 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.050 |
Biomarker
|
disease |
BEFREE |
We found SOX-13 antibodies to be present in 11 of 125 (8.8%) patients with newly diagnosed Type I diabetes and in 3 of 43 (7.0%) patients with latent autoimmune diabetes in adults.
|
11126406 |
2000 |
|
Diabetes
|
0.030 |
Biomarker
|
disease |
BEFREE |
Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients.
|
12021128 |
2002 |
|
Diabetes Mellitus
|
0.030 |
Biomarker
|
group |
BEFREE |
Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients.
|
12021128 |
2002 |
|
Diabetes
|
0.030 |
Biomarker
|
disease |
BEFREE |
We ascertained frequencies of autoantibodies to a suite of islet cell antigens including ICA512/IA2 and SOX13 in Asian Indians with Type 1 diabetes and in other forms of diabetes.
|
11323090 |
2001 |
|
Diabetes Mellitus
|
0.030 |
Biomarker
|
group |
BEFREE |
We ascertained frequencies of autoantibodies to a suite of islet cell antigens including ICA512/IA2 and SOX13 in Asian Indians with Type 1 diabetes and in other forms of diabetes.
|
11323090 |
2001 |
|
Diabetes
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets.
|
10871192 |
2000 |
|
Diabetes Mellitus
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets.
|
10871192 |
2000 |
|
Autoimmune Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
We conclude that ICA12 represents the minor antigens in autoimmune diabetes and that, as a minor antigen, ICA12 alone does not contribute significantly in revealing new cases of autoimmunity.
|
12021128 |
2002 |
|
Diabetes, Autoimmune
|
0.020 |
Biomarker
|
disease |
BEFREE |
We conclude that ICA12 represents the minor antigens in autoimmune diabetes and that, as a minor antigen, ICA12 alone does not contribute significantly in revealing new cases of autoimmunity.
|
12021128 |
2002 |
|
Latent Autoimmune Diabetes in Adults
|
0.020 |
Biomarker
|
disease |
BEFREE |
ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.
|
12021135 |
2002 |
|
Autoimmune Diseases
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Full-length SOX-13 was cloned from human brain mRNA, expressed by vitro transcription/ translation and used to detect autoantibodies by immunoprecipitation and radioligand assay in patients suffering from autoimmune diabetes or non-organ-specific autoimmune diseases.
|
11126406 |
2000 |
|
Diabetes, Autoimmune
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our data indicate that SOX-13 represents a minor target of autoantibodies in patients with autoimmune diabetes.
|
11126406 |
2000 |
|
Latent Autoimmune Diabetes in Adults
|
0.020 |
Biomarker
|
disease |
BEFREE |
We found SOX-13 antibodies to be present in 11 of 125 (8.8%) patients with newly diagnosed Type I diabetes and in 3 of 43 (7.0%) patients with latent autoimmune diabetes in adults.
|
11126406 |
2000 |
|
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, MMP10, SOX4 and SOX13 were verified as the target genes of FOXC1 for promoting CRC metastasis.
|
31650548 |
2020 |
|
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data suggests that the feedback loop of FUS/circ_002136/miR-138-5p/SOX13 played a crucial role in the regulation of angiogenesis in glioma.
|
30736838 |
2019 |
|
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
It was demonstrated that miR-185 levels are significantly and inversely correlated with SOX13 levels in these NSCLC tissues, suggesting that these findings have implications for translational application with respect to NSCLC diagnostics and therapy.
|
30210696 |
2018 |
|
Multiple Myeloma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
NEAT1 and SOX13 were highly expressed in MM patients and MM cell lines, and the patient survival rate and platelet count were significantly decreased in the highly expressed NEAT1 group.
|
30338809 |
2018 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
MiR-185 also inhibited tumor growth and suppressed SOX13 in nude mouse xenograft tumors.
|
30210696 |
2018 |
|
Mitochondrial Diabetes
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The cohort was further characterized by measurement of autoantibodies to carboxypeptidase H (CPH) and SOX13 using radioligand assays, and testing for genetic mutations associated with MODY3/MODY6 and mitochondrial diabetes.
|
16409568 |
2006 |